APAC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APAC, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia [Phase 2]